High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
about
Reconsidering early HIV treatment and supervised treatment interruptionsLimited durability of viral control following treated acute HIV infectionImpaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesThe role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergyImmunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyHIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.HIV preferentially infects HIV-specific CD4+ T cells.Immunity to HIV in Early LifeIn vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.Changes in function of HIV-specific T-cell responses with increasing time from infection.Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infectionEarly development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitutionT-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein.Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyEffector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person.CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells.Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferonsLymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjectsRelationship between circulating interleukin-10 and histological features in patients with chronic C hepatitisA lower viral set point but little immunological impact after early treatment during primary HIV infectionDistinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infectionChanges in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen loadAntigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals.Use of cytokines in infection.The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment".Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugsInduction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection.Therapeutic immunization strategies for the control of HIV-1.Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy.Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.
P2860
Q24796745-76F91D1A-D8ED-448A-9D95-8D32B064B4ABQ24804986-A06F0A75-689E-4FA3-8E75-7F2BC3733ACEQ27477797-EB79D7F1-2280-4FDA-88EE-5ED79730CEEFQ28484046-A133C793-FE4C-4D36-8DE7-0AD9BAE77CC9Q33279519-205D7E83-5294-45E0-9FBC-9ECC054E1394Q33427803-852D2A7E-0CD7-4D98-BFB3-4E4BF9931694Q33637584-B861F350-B159-4370-A154-B9F5B7AFEB88Q33731771-0820BAE5-CA98-4616-B6E4-0D0B7E9D84A3Q33958893-FCF9CFB0-CA56-4109-BA4E-2F8F83490D18Q34033051-C8EDDD41-C3A7-4922-A63D-122F9E688572Q34050143-9C657CA5-D26B-49AC-81B6-9C0B021F5ADCQ34142433-1E87D05C-0367-4102-881D-BBC57A47A166Q34159342-9A74790F-6D19-4BBC-AF7B-F20F31EEA58AQ34200151-FD246933-7E8E-463A-9260-5CC2ABA1C16CQ34325840-3BA41FE4-9EAB-4F2B-B915-C79EAD98195AQ34448446-36ECCFAE-3E79-4AAE-8A43-7B17E3247B54Q34470969-8DA18111-5675-4E99-9FFD-31467DFFF965Q34498993-36814480-02E3-4327-A37D-E51B14606E14Q34550760-7D19A64D-D27F-4A5C-B3C4-77EE202B3D51Q34650563-C833158D-B3C7-4213-9C41-D89965B11CB3Q34717597-F3C48C52-1DF1-45DD-A2AA-54672150BEE8Q34730855-B006BED6-02C2-46CB-8980-010AB0D0CE07Q35001377-C00C6E64-30D8-4560-BE6B-17CD85F4F2D5Q35066683-E2212237-54AF-4B7B-99F4-FA25AA5BE728Q35101557-ABD47A3A-B0F7-4936-9882-6B9DBC025A81Q35140055-07766A73-9850-4FA8-95B4-FDD879D13F2AQ35153496-CE81387E-71F8-4882-B6AC-8B24BEAE1F32Q35165793-FD5F54C4-0333-4073-AA49-D611B1DF9529Q35323147-07F83211-5496-44C9-933B-29250B549F0BQ35784244-C3C35D46-3906-4DCE-9F19-9B1068560766Q35784804-F4521D79-65FE-4D0E-8E30-450A798761A2Q35923352-EA95C2BE-B0E5-44CE-AE48-E64155B55A5AQ35967372-77D616FB-638A-4734-927E-5705C00DB8B1Q36142172-64400E6D-FA05-4A62-ABFC-8BA0470A7EB4Q36149329-DC842FE0-B41C-42B1-B98F-4FDACD4A1BEDQ36154837-6585B53E-8653-4B0C-B717-9820B8A8FF90Q36228123-33E94EA4-483F-408A-B68F-86DE6F1B82BCQ36238709-E7212D2F-B860-454C-ABD2-46A18752B296Q36242314-E05D44CB-0859-4BEB-A23C-7DC3925A62DDQ36315197-BFED2931-46F6-40DD-A033-B79B5F723588
P2860
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@ast
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@en
type
label
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@ast
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@en
prefLabel
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@ast
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@en
P2093
P2860
P356
P1476
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
@en
P2093
Davey RT Jr
Hallahan CW
Iyasere CA
Shupert WL
P2860
P304
13878-13883
P356
10.1073/PNAS.251539598
P407
P577
2001-11-01T00:00:00Z